New Immunotherapy Drug Helps Treat Bladder Cancer

Posted: Jun 6 2016, 6:50am CDT | by , in News | Latest Science News


New Immunotherapy Drug Helps Treat Bladder Cancer
Getty Images
  • Novel Medicine lends Promise of a New Day to Bladder Cancer Sufferers

A novel immune therapy medicine has lent a promise of a new day to bladder cancer sufferers.

A new drug that has immune-boosting properties has given a new lease on life to bladder cancer patients. While the scientists do not have everything figured out just yet, it is nevertheless a fresh start that may prove liberating in the final analysis.

It treats the dreaded and deadly disease by using the body’s own immune system as a protector. This is a novel approach that just might work where other palliative measures failed desperately at the task. 

The drug is called atezolizumab. It goes by its trademark name which is Tecentriq. This works in a manner very like Keytruda. The latter is a drug which helped former President Jimmy Carter conquer his melanoma.

In over 24% of the bladder cancer sufferers, the drug caused the tumors to stop dead in their tracks. It also managed to help the tumors undergo a 30% reduction in their size.

Immunotherapy is a great way of allowing the body’s problems to be solved through the body alone. It tends to forgo any external damaging practices such as chemotherapy or radiotherapy which are not the ideal form of treatment.  

The earliest attempts to boost the immune system were through revving it up. However, this tended to create certain unpleasant symptoms. It was also not very effective or efficient for that matter.

Then there are more advanced techniques such as disciplining the immune cells to attack the tumors that start to crop up in the body. The volumizing of these immune cells tends to work just perfectly in destroying the harmful cancer cells. Cancer cells are ordinary cells that have gone wild. The immune cells are different though and do not work everytime they are given a jolt. 

This new drug tends to get to work on the immune cells in a straightforward manner. The monoclonal antibodies boost the immune system and force it to engulf the cancer cells.

Tecentriq got its first approval from the FDA  about 30 days ago. Yet there is a catch to its sale in the market. It is very costly and will put a dent in anyone’s wallet.

The cost price is $12,500 per month, according to HealthDay. However, such a price is reasonable when you see how good it is at saving the lives of cancer sufferers. It is a great advance and giant step in the direction of cancer elimination for the benefit of humanity. 

You May Like


The Author

<a href="/latest_stories/all/all/20" rel="author">Sumayah Aamir</a>
Sumayah Aamir (Google+) has deep experience in analyzing the latest trends.




Leave a Comment

Share this Story

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook

You Also Like


Read the Latest from I4U News